TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$20.20
-5.47% today
Updated 2026-04-29
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C6.5
Quality
B2.0
Profitability
F6.7
Valuation
B5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$24.00
+18.81%
12-Month target
—
—
Intrinsic (DCF)
$69.50
Margin of safety
+72.45%
1 Strong Buy5 Buy10 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $39.00M — positive
+ 72.45% below intrinsic value
Risks
- Thin margins at -6.77%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $516.41M | $618.73M | $610.78M | $642.82M | $642.82M |
| Net income | $-166.00M | $-255.10M | $-182.63M | $-43.54M | $-16.25M |
| EPS | — | — | — | — | $-0.35 |
| Free cash flow | $-165.27M | $-64.72M | $-5.73M | $130.12M | $39.00M |
| Profit margin | -32.15% | -41.23% | -29.90% | -6.77% | -6.77% |
Peer comparison
Smart narrative
10X Genomics Inc trades at $20.20. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $642.82M. with profit margins at -6.77%. Our DCF model estimates intrinsic value at $69.50.
Frequently asked questions
What is 10X Genomics Inc's stock price?
10X Genomics Inc (TXG) trades at $20.20.
Is 10X Genomics Inc overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell). DCF value $69.50.
What is the price target of 10X Genomics Inc (TXG)?
The analyst target price is $24.00, representing +18.8% upside from the current price of $20.20.
What is the intrinsic value of 10X Genomics Inc (TXG)?
Based on our DCF model, intrinsic value is $69.50, a +72.5% margin of safety versus $20.20.
What is 10X Genomics Inc's revenue?
TTM revenue is $642.82M.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.05x
ROE-5.78%
Beta2.17
50D MA$21.21
200D MA$16.84
Shares out0.12B
Float0.12B
Short ratio—
Avg volume2.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—